These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22111834)

  • 1. Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growth.
    Vine KL; Indira Chandran V; Locke JM; Matesic L; Lee J; Skropeta D; Bremner JB; Ranson M
    Curr Cancer Drug Targets; 2012 Jan; 12(1):64-73. PubMed ID: 22111834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor.
    Indira Chandran V; Matesic L; Locke JM; Skropeta D; Ranson M; Vine KL
    Cancer Lett; 2012 Mar; 316(2):151-6. PubMed ID: 22115965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Belfiore L; Saunders DN; Ranson M; Vine KL
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32645963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma.
    Stutchbury TK; Al-Ejeh F; Stillfried GE; Croucher DR; Andrews J; Irving D; Links M; Ranson M
    Mol Cancer Ther; 2007 Jan; 6(1):203-12. PubMed ID: 17237280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.
    Vine KL; Lobov S; Indira Chandran V; Harris NL; Ranson M
    Pharm Res; 2015 Mar; 32(3):1045-54. PubMed ID: 25231010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG-transferrin conjugated TRAIL (TNF-related apoptosis-inducing ligand) for therapeutic tumor targeting.
    Kim TH; Jo YG; Jiang HH; Lim SM; Youn YS; Lee S; Chen X; Byun Y; Lee KC
    J Control Release; 2012 Sep; 162(2):422-8. PubMed ID: 22824780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment.
    Bratti M; Stubbs E; Kolodych S; Souchet H; Kelly L; Merlin J; Marchal M; Castellano R; Josselin E; Pasquer H; Benajiba L; Puissant A; Koniev O; Collette Y; Belanger C; Hermine O; Monteiro RC; Launay P
    Mol Cancer Ther; 2024 Aug; 23(8):1159-1175. PubMed ID: 38641421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
    Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R
    Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.
    Zhang Y; Kenny HA; Swindell EP; Mitra AK; Hankins PL; Ahn RW; Gwin K; Mazar AP; O'Halloran TV; Lengyel E
    Mol Cancer Ther; 2013 Dec; 12(12):2628-39. PubMed ID: 24061648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
    Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
    Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines.
    Al-Ejeh F; Croucher D; Ranson M
    Exp Cell Res; 2004 Jul; 297(1):259-71. PubMed ID: 15194441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
    Wu H; Yao L; Mei J; Li F
    Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin-oligomers as potential carriers in anticancer drug delivery.
    Lim CJ; Shen WC
    Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective targeting of 2'-deoxy-5-fluorouridine to urokinase positive malignant cells in vitro.
    Vine KL; Locke JM; Bremner JB; Pyne SG; Ranson M
    Bioorg Med Chem Lett; 2010 May; 20(9):2908-11. PubMed ID: 20363130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.